DNTH Archived Articles
Dianthus Therapeutics, Inc.: Pioneering Complement-Targeted Therapies for Autoimmune and Inflammatory Diseases
Published on November 17, 2024
Dianthus Therapeutics, Inc. (NASDAQ:DNTH): A Promising Biotech Poised for Significant Growth
Published on September 24, 2024